Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fed-state crossover equivalence study of modified-release hydromorphone versus Palladon retard in chronic severe pain
2009-014518-83Phase 3Active
- Sponsor
- Acino
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of hydromorphone in chronic pain (2 arms), sponsored by Acino. Primary endpoint: Pain intensity difference between treatments. Started Sep 2009; status: active.
02
Drugs
hydromorphone
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2009-014518-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014518-83.